Pharmacogenetics: potential for individualized drug therapy through genetics
- 1 November 2003
- journal article
- review article
- Published by Elsevier in Trends in Genetics
- Vol. 19 (11), 660-666
- https://doi.org/10.1016/j.tig.2003.09.008
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- A vision for the future of genomics researchNature, 2003
- Pharmacology and Physiology of Human Adrenergic Receptor polymorphismsAnnual Review of Pharmacology and Toxicology, 2003
- Personalized medicine: revolutionizing drug discovery and patient careTrends in Biotechnology, 2001
- PharmacogeneticsHuman Molecular Genetics, 2001
- Pharmacogenomics: The Inherited Basis for Interindividual Differences in Drug ResponseAnnual Review of Genomics and Human Genetics, 2001
- C825T Polymorphism of the G Protein β 3 -Subunit and Antihypertensive Response to a Thiazide DiureticHypertension, 2001
- Drug Target PharmacogenomicsAmerican Journal of PharmacoGenomics, 2001
- The Role of α-Adducin Polymorphism in Blood Pressure and Sodium Handling Regulation May Not Be Excluded by a Negative Association StudyHypertension, 1999
- Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complicationsThe Lancet, 1999
- Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapyAtherosclerosis, 1995